The pharma market access conferences worth a commercial team’s time in 2026 share one trait: they put market access, HEOR, and medical affairs leaders in the same room as the payers and health system executives who actually control access.
Reaching prescribers is not the same as winning system adoption, and the events below are where that second, harder conversation happens. Several have already taken place this year, so the next scheduled date is noted where the 2026 edition has passed.
1. AMCP Nexus 2026
October 26-29, 2026 | San Diego, CA
AMCP Nexus gathers close to 3,000 managed care pharmacy professionals from health plans, pharmacy benefit managers, and biopharmaceutical companies. Its program runs straight through the access agenda: formulary development, value-based care, real-world evidence, and biosimilars. For market access teams that need a direct read on payer expectations, it is the core managed care community event still on the 2026 calendar.
2. The Health Management Academy Executive Convening Forums
September and October 2026 | Boston, MA
Payer events tell you how plans think. The Executive Convening Forums hosted by The Health Management Academy (THMA) tell you how health systems decide. Each forum is a small, closed-door, retreat-style meeting that places senior industry leaders alongside the health system executives who govern formulary positioning and access execution inside their networks.
3. Pharma Pricing & Market Access Innovation Summit
November 2026
The second annual edition of this summit convenes senior leaders across pricing, HEOR, market access, payer engagement, and regulatory affairs. The agenda centers on the pressures reshaping access today: affordability, shifting health technology assessment expectations, patient-centric access pathways, and the role of digital tools in evidence generation and reimbursement. It suits pricing and access strategy teams working across global markets.
4. ACCC National Oncology Conference
October 2026
The Association of Cancer Care Centers hosts its 43rd National Oncology Conference, a gathering of clinicians, administrators, navigators, and patient advocates focused on cancer care delivery and the access barriers around it. The conference also presents the ACCC Innovator Awards. It is most useful for teams whose products depend on adoption inside community oncology programs.
5. Access USA
March 23-25, 2027 | National Harbor, MD
Access USA brings three patient-access events under one roof: patient assistance and access programs, hub and specialty pharmacy models, and a rare disease summit. With patient assistance programs under pressure from recent policy and budget changes, this is the dedicated forum for affordability and patient support strategy. The 2026 edition concluded in March; the next runs March 23-25, 2027, at National Harbor.
6. SCOPE Summit
February 2027 | Orlando, FL
SCOPE is primarily a clinical operations summit, but its newer market access track and real-world evidence programming make it relevant for access teams that want to shape study design early. Integrating access strategy into trial planning, and collecting the healthcare resource use that supports economic value, is easier when those conversations start in development. The 2026 edition has passed; SCOPE returns in February 2027.
Choosing the Right Market Access Events for 2026
The right calendar follows the question a team is trying to answer. For payer and managed care strategy, AMCP Nexus is the anchor. For health system adoption and formulary access, the executive forums put the decision-makers in the room. For pricing and HTA strategy, the pricing summit is the fit, and for patient access and affordability, Access USA covers the ground. Most access teams are best served by spanning a few of these across 2026 and into early 2027 rather than betting on a single event.
